Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX).

Full DD Report for PGNX

You must become a subscriber to view this report.


Recent News from (NASDAQ: PGNX)

CytoDyn's PRO 140: A Potential Victim Of Poor Clinical Development
So here it goes. I've written several articles, and preached to several wonderful choirs about some companies that I love. And the choirs sang beautifully. This time it's going to be a little different as I lay out a somewhat negative view on a company. To those invested in this stock, I apolo...
Source: SeekingAlpha
Date: September, 13 2018 13:06
Midday Gainers / Losers (09/13/2018)
Gainers:  PI +41% . GNC +27% . TLRY +18% . PDD +17% . MNLO +14% . ABAC +14% . HMHC +14% . LEJU +13% . CKPT +13% . EVRI +13% . More news on: Impinj, Inc., GNC Holdings, Inc., Tilray, Inc., Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 13 2018 12:41
Today's Research Reports on Trending Tickers: Progenics Pharmaceuticals and Foamix Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / September 13, 2018 / U.S. markets were mixed on Wednesday as technology shares declined, dragging the Nasdaq into the red. The Dow Jones Industrial Average climbed 0.11 percent to close at 25,998.92, while the S&P 500 Index jumped 0.04 percent to close at 2,88...
Source: ACCESSWIRE IA
Date: September, 13 2018 08:00
After Hours Gainers / Losers (09/12/2018)
Top Gainers: PI +33.9% . BXG +11.9% . TLRD +4.8% . BRFS +2.5% . GSKY   +2.4% . More news on: Impinj, Inc., Bluegreen Vacations Corp., Tailored Brands, Inc, Stocks on the move, , Read more ...
Source: SeekingAlpha
Date: September, 12 2018 17:35
Progenics Pharma shares halted pending news
Nasdaq has suspended trading in Progenics Pharmaceuticals (NASDAQ: PGNX ) pending the release of news. More news on: Progenics Pharmaceuticals Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: September, 12 2018 16:13

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-09-145.805.9956.325.696,116,668
2017-12-285.915.855.9585.77657,026
2017-12-276.035.916.0975.85714,118
2017-12-266.045.976.07425.92511,789
2017-12-226.056.006.0695.88723,783

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-07237,820305,10377.9474Short
2018-12-06145,528221,15965.8024Short
2018-12-04222,746332,43267.0050Short
2018-12-03197,145368,89053.4428Short
2018-11-30161,5171,409,28011.4610Cover

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on PGNX.


About Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX)

Logo for Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX)

Not available

 

Contact Information

 

 

Current Management

  • Paul J. Maddon / CEO
  • Ronald J. Prentki / President

Current Share Structure

  • Market Cap: $525,346,137 - 05/18/2018
  • Issue and Outstanding: 72,661,983 - 03/05/2018

 


Recent Filings from (NASDAQ: PGNX)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: September, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 10 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: August, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Prospectus filed under Rule 424(b)(5)
Filing Type: 424B5Filing Source: edgar
Filing Date: August, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 07 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 31 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: July, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 31 2018
Amendment to the SC 13G filing
Filing Type: SC 13G/AFiling Source: edgar
Filing Date: July, 10 2018

 

 


Daily Technical Chart for (NASDAQ: PGNX)

Daily Technical Chart for (NASDAQ: PGNX)


Stay tuned for daily updates and more on (NASDAQ: PGNX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: PGNX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in PGNX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of PGNX and does not buy, sell, or trade any shares of PGNX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/